Donor immune cells bolster transplant against blood cancer relapse
NCT ID NCT05115630
Summary
This study tested whether adding 'off-the-shelf' natural killer (NK) immune cells from a donor could make stem cell transplants more effective for adults with high-risk forms of leukemia. The goal was to see if this combination was safe and could help prevent the cancer from coming back after the transplant. Researchers enrolled 24 patients with acute myeloid leukemia, myelodysplastic syndrome, or chronic myeloid leukemia to evaluate this approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Caner Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.